Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 234 participants.
Also called NCT05817851
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 234 participants
- Sponsor
- Registry
-
NCT05817851
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05817851. Randomized; no masking; primary purpose treatment. Start 2023-12-27 (actual); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.
- Acronym
- VICEPAC
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)
- Intervention (Drug)
- standard treatment
- Lead sponsor
- Centre Hospitalier de Bethune
- Collaborator
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Collaborator
- University Hospital, Lille
Record details
- Record id
cardio:ct-nct05817851- Content hash
2a1f0d4cecea4630b5bb49bdfa165f9f2d9c92840040a98f36b61825d05da24b